Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | BG5J4 | IM / LA |
VACCINE WAS CONSIDERED EXTRANEOUS AND UNNECESSARY AS PATIENT RECEIVED DOSE IN 2023
NONE-REPORTED
NONE-REPORTED
NONE-REPORTED
NO ALLERGIES
NONE